COMPARATIVE PHARMACOECONOMIC ANALYSIS OF THE APPLICATION OF POSACONAZOLE, FLUCONAZOLE AND ITRACONAZOLE WITH THE PURPOSE OF PRIMARY PREVENTION OF INVASIVE FUNGAL INFECTION IN PATIENTS WITH NEUTROPENIA DURING CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA OR MYELODYSPLASTIC SYNDROME

被引：0

作者：

Krysanov, I ^{[1
]}

Krysanova, V ^{[2
]}

机构：

[1] Moscow Natl Univ Food Prod, Postgrad Med Inst, Moscow, Russia

[2] IM Sechenov First Moscow State Med Univ, Moscow, Russia

来源：

VALUE IN HEALTH | 2014年 / 17卷 / 07期

关键词：

D O I：

10.1016/j.jval.2014.08.1691

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PSY61

引用

页码：A532 / A532

页数：1

共 37 条

[21] FACTORS ASSOCIATED TO INVASIVE FUNGAL INFECTION: EXPERIENCE IN PATIENTS WITH ACUTE LEUKEMIA AND MYELODYSPLASTIC SYNDROME (SMD) IN OUR CENTRE
Yus Cebrian, F.
Costilla Barriga, L.
de Portugal Casana, Coello C.
Tercero-Mora, R. M.
Godoy Molias, A. C.
De Rueda Ciller, B.
Delgado Beltran, M. P.
HAEMATOLOGICA, 2015, 100 : 259 - 259
[22] Early Diagnostic Procedure and Treatment for Invasive Fungal Infection Centered on Invasive Aspergillosis in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia
Kyo, Kouhei
Okatani, Takeshi
Imanaka, Ryota
Itagaki, Mitsuhiro
Katayama, Yuuta
Kyo, Taiichi
BLOOD, 2011, 118 (21) : 671 - 671
[23] Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison
Tormo, Mar
Perez-Martinez, Ariadna
Calabuig, Marisa
Carlos Hernandez-Boluda, Juan
Amat, Paula
Navarro, David
Solano, Carlos
MYCOSES, 2018, 61 (03) : 206 - 212
[24] Antifungal Prophylaxis With Posaconazole Is Effective in Preventing Invasive Fungal Infections in Acute Myeloid Leukemia Patients During Induction and Salvage Chemotherapy
Wong, Gee-Chuan
Halim, Nurul Aidah Abdul
Tan, Ban-Hock
CLINICAL INFECTIOUS DISEASES, 2015, 61 (08) : 1351 - U150
[25] Risk factors for invasive fungal infection in 5-azacytidine treated patients with acute myeloid leukemia and myelodysplastic syndrome
Tey, Amanda
Shaw, Briony
Cardamone, Luke
Shepherd, Sam
Paul, Eldho
Rogers, Ben
Shortt, Jake
EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (02) : 181 - 189
[26] INVASIVE FUNGAL INFECTION (IFI) IN PATIENTS WITH ACUTE MYELOGENOUS LEUKAEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS)-TREATMENT COST FROM HOSPITAL PERSPECTIVE
Berger, K.
Cornely, O. A.
Hoppe-Tichy, T.
Kiehl, M.
Knoth, H.
Rieger, C.
Thalheimer, M.
Schuler, U.
Ullmann, A. J.
Ostermann, H.
VALUE IN HEALTH, 2008, 11 (06) : A478 - A479
[27] Outcome and Medical Costs of Patients with Invasive Aspergillosis and Acute Myelogenous Leukemia-Myelodysplastic Syndrome Treated with Intensive Chemotherapy: An Observational Study
Slobbe, Lennert
Polinder, Suzanne
Doorduijn, Jeanette K.
Lugtenburg, Pieternella J.
el Barzouhi, Abdelilah
Steyerberg, Ewout W.
Rijnders, Bart J. A.
CLINICAL INFECTIOUS DISEASES, 2008, 47 (12) : 1507 - 1512
[28] Antifungal Prophylaxis With Posaconazole Is Effective in Preventing Invasive Fungal Infections in Acute Myeloid Leukemia Patients During Induction and Salvage Chemotherapy Reply
Pagano, Livio
Tumbarello, Mario
CLINICAL INFECTIOUS DISEASES, 2015, 61 (08) : 1352 - 1352
[29] β-D-glucan as a diagnostic adjunct for invasive fungal infections:: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome
Odabasi, Z
Mattiuzzi, G
Estey, E
Kantarjian, H
Saeki, F
Ridge, RJ
Ketchum, PA
Finkelman, MA
Rex, JH
Ostrosky-Zeichner, L
CLINICAL INFECTIOUS DISEASES, 2004, 39 (02) : 199 - 205
[30] INVASIVE FUNGAL DISEASE IN PEDIATRIC ACUTE-LEUKEMIA PATIENTS WITH FEVER AND NEUTROPENIA DURING INDUCTION CHEMOTHERAPY - A MULTIVARIATE-ANALYSIS OF RISK-FACTORS
WILEY, JM
SMITH, N
LEVENTHAL, BG
GRAHAM, ML
STRAUSS, LC
HURWITZ, CA
MODLIN, J
MELLITS, D
BAUMGARDNER, R
CORDEN, BJ
CIVIN, CI
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (02) : 280 - 286

← 1 2 3 4 →